跳至主要内容
临床试验/ISRCTN46322781
ISRCTN46322781已完成1 期

Acute and long-term effects of endocannabinoid modulation in individuals at high risk for psychosis: an experimental study

King's College London0 个研究点目标入组 33 人开始时间: 2016年10月12日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
33

研究概览

简要总结

2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30167644 results 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32921794/ (added 08/11/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged 18- 35 years
  • 2. Right-handed
  • 3. Ultra high risk (UHR) for psychosis individuals being supported by OASIS (https://www.oasislondon.com), a large clinical service for this group
  • 4. Have positive psychotic symptoms and anxiety symptoms, as defined using the Positive and Negative syndrome scale (PANSS) and the State-Trait Anxiety Inventory (STAI)
  • 5. Medication naïve

排除标准

  • 1. History of previous psychotic disorder or manic episode
  • 2. Current DSM IV diagnosis of substance dependence (except cannabis dependence)
  • 3. Neurological disorders (eg., epilepsy) or severe intercurrent illness that may put the person at risk
  • 4. IQ of less than 70
  • 5. Female subject who is unwilling to use two forms of contraception (one of which must be a barrier contraception), pregnant, lactating or planning pregnancy during the course of the study and 3 months from the date of the last dose and a male subject whose partner is of child-bearing potential and unwilling to use a barrier method of contraception along with their partner

研究者

相似试验